Zi‐Zhan Li

647 total citations
41 papers, 403 citations indexed

About

Zi‐Zhan Li is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Zi‐Zhan Li has authored 41 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Otorhinolaryngology. Recurrent topics in Zi‐Zhan Li's work include Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (4 papers). Zi‐Zhan Li is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (4 papers). Zi‐Zhan Li collaborates with scholars based in China, Australia and Canada. Zi‐Zhan Li's co-authors include Lin‐Lin Bu, Lei‐Ming Cao, Nian‐Nian Zhong, Bing Liu, Yao Xiao, Z. J. Shang, Fang‐Yi Huo, Qiuji Wu, C. F. Xu and Hanqi Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Zi‐Zhan Li

34 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zi‐Zhan Li China 13 116 104 68 65 63 41 403
Nian‐Nian Zhong China 13 102 0.9× 107 1.0× 61 0.9× 55 0.8× 47 0.7× 36 331
Elizabeth M. Gillies United States 12 142 1.2× 130 1.3× 58 0.9× 41 0.6× 69 1.1× 16 438
Qingang Hu China 15 192 1.7× 116 1.1× 60 0.9× 88 1.4× 157 2.5× 37 555
Wu‐tong Ju China 11 128 1.1× 147 1.4× 48 0.7× 91 1.4× 78 1.2× 27 358
Elham Alsahafi Saudi Arabia 5 284 2.4× 160 1.5× 68 1.0× 93 1.4× 36 0.6× 7 491
Lovisa Farnebo Sweden 13 261 2.3× 269 2.6× 54 0.8× 92 1.4× 67 1.1× 22 577
Chad E. Galer United States 12 138 1.2× 125 1.2× 55 0.8× 32 0.5× 81 1.3× 16 365
Nidal Muhanna Canada 11 67 0.6× 74 0.7× 63 0.9× 42 0.6× 182 2.9× 26 676
Anxun Wang China 10 169 1.5× 95 0.9× 24 0.4× 31 0.5× 44 0.7× 17 343

Countries citing papers authored by Zi‐Zhan Li

Since Specialization
Citations

This map shows the geographic impact of Zi‐Zhan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Zhan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Zhan Li more than expected).

Fields of papers citing papers by Zi‐Zhan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi‐Zhan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Zhan Li. The network helps show where Zi‐Zhan Li may publish in the future.

Co-authorship network of co-authors of Zi‐Zhan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zi‐Zhan Li. A scholar is included among the top collaborators of Zi‐Zhan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi‐Zhan Li. Zi‐Zhan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zi‐Zhan, Yi Liu, Lei‐Ming Cao, et al.. (2025). Cuproptosis-based nanomedicine in cancer metastasis synergistic therapy. Acta Pharmaceutica Sinica B.
3.
Cao, Lei‐Ming, Yuan-ye Qiu, Zi‐Zhan Li, et al.. (2025). Extracellular Vesicles: Hermes between cancers and lymph nodes. Cancer Letters. 623. 217735–217735. 1 indexed citations
4.
Zhu, Wentao, Fang‐Yi Huo, Lei‐Ming Cao, et al.. (2025). Two-photon polymerization 3D printing of biomimetic microstructures for functionalizing surfaces to inhibit bacterial growth. Chemical Engineering Journal. 511. 161907–161907. 1 indexed citations
5.
Li, Zi‐Zhan, Yi Liu, Lei‐Ming Cao, et al.. (2025). ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy. Advanced Science. 12(35). e02154–e02154. 3 indexed citations
6.
Li, Zi‐Zhan, Wen-Tao Zhu, Nian‐Nian Zhong, et al.. (2024). Lymph node metastasis diagnosis of postoperative OSCC patients by analyzing extracellular vesicles in drainage fluid based on microfluidic isolation. Journal of Nanobiotechnology. 22(1). 586–586. 14 indexed citations
7.
Li, Zi‐Zhan, Nian‐Nian Zhong, Lei‐Ming Cao, et al.. (2024). Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors (Small 19/2024). Small. 20(19). 3 indexed citations
8.
Li, Zi‐Zhan, et al.. (2024). Immunometabolism in head and neck squamous cell carcinoma: Hope and challenge. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167629–167629. 5 indexed citations
9.
Yu, Yifu, Lei‐Ming Cao, Zi‐Zhan Li, et al.. (2024). Frequency of lymph node metastases at different neck levels in patients with oral squamous cell carcinoma: a systematic review and meta-analysis. International Journal of Surgery. 111(1). 1285–1300. 6 indexed citations
10.
Cao, Lei‐Ming, Nian‐Nian Zhong, Yang Chen, et al.. (2024). Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment. Cancer Letters. 598. 217095–217095. 15 indexed citations
11.
Wang, Kangning, Nian‐Nian Zhong, Lei‐Ming Cao, et al.. (2024). Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety. Life Sciences. 346. 122635–122635. 8 indexed citations
12.
Xu, Zhenyu, Zi‐Zhan Li, Lei‐Ming Cao, et al.. (2024). Seizing the fate of lymph nodes in immunotherapy: To preserve or not?. Cancer Letters. 588. 216740–216740. 21 indexed citations
13.
Li, Zi‐Zhan, Nian‐Nian Zhong, Lei‐Ming Cao, et al.. (2024). Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors. Small. 20(19). e2308731–e2308731. 31 indexed citations
14.
Li, Zi‐Zhan, Qi‐Wen Man, Tianfu Wu, et al.. (2024). Application of PRI-E–a combined learning method in oral and maxillofacial oncology education. Scientific Reports. 14(1). 8127–8127. 4 indexed citations
15.
Li, Zi‐Zhan, Nian‐Nian Zhong, Lei‐Ming Cao, et al.. (2024). Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives. Journal of Nanobiotechnology. 22(1). 135–135. 12 indexed citations
16.
Wei, Liya, et al.. (2024). The ending is not the end: Lymph node metastasis in oral squamous cell carcinoma. International Immunopharmacology. 146. 113917–113917. 6 indexed citations
17.
Li, Zi‐Zhan, et al.. (2024). Lymph node metastasis in cancer: Clearing the clouds to see the dawn. Critical Reviews in Oncology/Hematology. 204. 104536–104536. 17 indexed citations
18.
Xiao, Yao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.. (2023). Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care. Translational Oncology. 38. 101794–101794. 22 indexed citations
20.
Li, Zi‐Zhan, et al.. (2005). Potential role of disc repositioning in preventing postsurgical recurrence of traumatogenic temporomandibular joint ankylosis: a retrospective review of 17 consecutive cases. International Journal of Oral and Maxillofacial Surgery. 35(3). 219–223. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026